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Background: Aerobic capacity tests are important to evaluate exercise programs and to encourage individuals to
have a physically active lifestyle. Submaximal tests, if proven valid and reliable could be used for estimation of
maximal oxygen uptake (VO2max). The purpose of the study was to examine the criterion-validity of the submaximal
self-monitoring Fox-walk test and the submaximal Åstrand cycle test against a maximal cycle test in people with
rheumatoid arthritis (RA). A secondary aim was to study the influence of different formulas for age predicted maximal
heart rate when estimating VO2max by the Åstrand test.
Methods: Twenty seven subjects (81% female), mean (SD) age 62 (8.1) years, diagnosed with RA since 17.9 (11.7) years,
participated in the study. They performed the Fox-walk test (775 meters), the Åstrand test and the maximal cycle test
(measured VO2max test). Pearson’s correlation coefficients were calculated to determine the direction and strength of
the association between the tests, and paired t-tests were used to test potential differences between the tests. Bland
and Altman methods were used to assess whether there was any systematic disagreement between the submaximal
tests and the maximal test.
Results: The correlation between the estimated and measured VO2max values were strong and ranged between r = 0.52
and r = 0.82 including the use of different formulas for age predicted maximal heart rate, when estimating VO2max by the
Åstrand test. VO2max was overestimated by 30% by the Fox-walk test and underestimated by 10% by the Åstrand test
corrected for age. When the different formulas for age predicted maximal heart rate were used, the results showed that
two formulas better predicted maximal heart rate and consequently a more precise estimation of VO2max.
Conclusions: Despite the fact that the Fox-walk test overestimated VO2max substantially, the test is a promising method
for self-monitoring VO2max and further development of the test is encouraged. The Åstrand test should be considered as
highly valid and feasible and the two newly developed formulas for predicting maximal heart rate according to age are
preferable to use when estimating VO2max by the Åstrand test.
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Rheumatoid arthritis (RA) is a chronic inflammatory dis-
ease with primary symptoms of joint pain, fatigue and
major impact on functioning and health. People with RA
have an increased risk of cardiovascular events which
might result from an interaction between traditional risk
factors, those related to chronic inflammation and pos-
sibly to physical inactivity [1,2].
Considering that physical activity (PA) is an important
part of treatment and care in patients with RA, it is rec-
ommended that clinicians promote PA in this group [3].
In line with evidence based practice, the effectiveness of
a period of PA should be assessed and evaluated. Since
self-monitoring has been identified as an effective tech-
nique of increasing PA, clinicians should encourage
patients to regularly self-monitor PA progress outside
of the clinic [4]. The Fox-walk test is a novel method
to estimate maximal oxygen uptake (VO2max) by walk-
ing on an outdoor track. It is easy to perform, self-
administered and requires no expensive equipment.
The Fox-walk test is highly reliable in people with RA
with an intra class correlation (ICC) of 0.98 (95% Con-
fidence Interval, CI: 0.95-0.99) and the reliability is not
influenced by disease-related factors [5]. Moreover, the
Fox-walk test is also a reliable method to monitor improve-
ments in VO2max. On a group level, the smallest detectable
differences should be an increase of >1 ml · kg−1 · min−1
(or 2.4%) to show a clinically relevant difference, whereas
on an individual level, an increase of >2.8 ml · kg−1 · min−1
(or 9.4%) indicates a clinically relevant difference in
VO2max [5]. However, the test still needs to be validated in
people with RA.
Assessment of aerobic fitness usually takes place in a
clinical setting and is commonly supervised by a health
professional as a test leader. One of the most com-
monly used submaximal cycle ergometry tests, suitable
for a clinical setting, is the Åstrand test [6]. The esti-
mation of the VO2max from the test is based on a linear
relationship between mechanical load, oxygen uptake
and heart rate (HR) obtained during the test. Although
the test is recommended as an assessment method in
physiotherapy guidelines in the management of patients
with RA, it has not yet been tested for validity in this
group [7].
If true maximal HR is not known, a prediction of the
individual’s maximal HR is usually needed for estimation
of VO2max by the Åstrand test. To do this an age-
correction factor was incorporated in 1960 to account
for the decrease in maximal HR with age [8]. However,
both this age correction factor and the most wide spread
formula for age predicted maximal HR (220-age), de-
veloped in 1971 [9] may underestimate maximal HR
in an elderly healthy population [10]. In order to in-
crease the precision of the predicted maximal HR, andconsequently the estimated VO2max, it has recently been
suggested that the formula should be modified [10,11].
Neither of these formulas have been evaluated in submaxi-
mal tests in people with RA.
Purpose
The purpose of this study was to examine the criterion-
validity of the submaximal self-monitoring Fox-walk test
and the submaximal Åstrand test against a maximal
cycle test in people with RA. A secondary aim was to
study the influence of different formulas for age pre-




Thirty participants diagnosed with RA according to the
1987 American College of Rheumatology criteria [12],
aged 44–75 years, independent in daily living and with
no Swedish language difficulties, were recruited from an
ongoing PA trial, the PARA 2010 study (http://www.con-
trolled-trials.com/ISRCTN25539102/). Participants were
informed about the present study and signed consent
was obtained. Three participants dropped out due to
illness or personal reasons. Data on demographics,
disease-related characteristics, medication and level
of PA of the remaining 27 participants (22 females and
5 males) are displayed in Table 1. All subjects in this
sample had been encouraged to exercise regularly the
past year.
Procedure
Participants were assessed with the submaximal Fox-walk
test and the submaximal Åstrand test for estimation of
VO2max and a maximal exercise cycle test for direct meas-
urement of VO2max (measured VO2max test). For practical
reasons, the Fox-walk test was performed at least three
days (at most five days) prior to or after the cycle tests.
The submaximal Åstrand cycle test was performed on the
same test occasion as the VO2max test, separated by five
minutes rest in between each test. The participants were
informed to refrain from smoking and vigorous activity
the day before the cycle test and from heavy meals within
two hours before the test.
Assessments
Demographics were collected with a self-administered
questionnaire. General health perception [13], fatigue
[14,15] and pain [16] were rated on visual analogue scales
(VAS, 0–100 mm), and activity limitation was assessed
with the Stanford Health Assessment Questionnaire
(HAQ) [17]. Data on disease duration, disease activity
score (DAS 28) and medication was retrieved from patient
files. Standing height was measured to the nearest 0.5 cm
Table 1 Characteristics of participants (n = 27)
Characteristics
Demographics
Gender: female, n (%) 22 (81)
Age (yrs), mean (SD) 62 (8)
Anthropometrics
Weight, kg mean (SD) 70 (14)
Height, cm, mean (SD) 170 (10)
BMI, mean (SD) 24.3 (3.5)
RA-related characteristics
Disease duration (yrs), median (IQR) 15 (7–30)
DAS 28, median (IQR)1 2.4 (2.2-2.8)
General health (VAS), 0–100, median (IQR) 14 (7–25)
Fatigue (VAS), 0–100, median (IQR) 19 (6–35)
Pain (VAS), 0–100, median (IQR) 19 (7–28)
Activity limitation (HAQ) 0–3, median (IQR) 0.379 (0–0.750)
RA- medication2
Biologics, n (%) 17 (63)
DMARD, n (%) 17 (63)
NSAID, n (%) 8 (30)
Corticosteroids, n (%) 5 (19)
Other medication
Beta adrenergic antagonists, n (%) 3 (11)
Physical activity
30 minutes moderate intensity, times/week past year,
median(IQR) (n = 26)
3.1 (2.2-4.0)
Circuit training, times/week past year, median (IQR)
(n = 26)
1.3 (0.7-1.7)
1n = 22, 2n = 25, SD = Standard deviation, BMI = Body mass index: weight (kg) /
height (m2), DAS 28 = Disease activity score, VAS = visual analogue scale,
HAQ =Health Assessment Questionnaire, IQR = Inter quartile range, DMARD =
Disease modifying anti rheumatic disease, NSAID = Non steroidal anti
inflammatory drug.
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Composition Analyzer (Tanita Corporation of America,
IInc. Illinois, USA). Body mass index (BMI) was calculated
as weight in kilograms divided by the square of the height
in metres and perceived exertion was rated on the Borg’s
RPE scale [18].
Fox-walk test
The Fox-walk test tracks are situated on public places
throughout Sweden and other European countries and
consist of different lengths, ranging from 400 meters
to 2500 meters. The test is performed walking or run-
ning, but only people with good aerobic fitness are
recommended to do the test running. People have free
access to the tracks. By recording the duration, time
of walking or running and using this information, the
result of the test can be obtained from a specific website(http://www.halsosparet.se/). The Fox-walk test was ad-
ministered by two trained test leaders. The length of
the track used in the present study was 775 meters
and the height difference was two meters. The track
was located centrally in Stockholm, Sweden. To get fa-
miliar with the track and as a warm up session, the
test leaders walked the track together with the partici-
pants and explained the test procedure. Preceding the
test, general health, fatigue and lower limb pain were
rated and participants were instructed to walk the
track with maximal effort without running. The test
leaders recorded the time (Silva stopwatch, Sollentuna,
Sweden) and collected data on perceived exertion with
the Borg scale. Lower limb pain was rated again after
the test was completed.
A previously developed equation, derived from a study
with healthy people (unpublished observations) was used
to estimate VO2max using the Fox-walk test. Gender, age,
height of the person, BMI, walking speed, length of the
track as well as the track ascendance are entered in to the
equation: 46.5 + 5.08 · sex (1 =men, 2 = women) -0.66 · age
(years) -23.3 · height (meters)-0.388 · BMI (kg/m2) +24.95 ·
walking speed (m/s)-0.146 · total track ascendance (m). In
the unpublished study the Fox-walk test was validated
against laboratory tests of aerobic capacity on a cycle erg-
ometer. The different variables in the equation were tested
on their impact on the predictive value (sensitivity and
specificity) with stepwise linear regressions and the equa-
tion was adjusted after these results.
Åstrand’s submaximal cycle test (Åstrand test)
An electrically braked cycle ergometer (Rodby, RE990,
Rodby innovation AB, Uppsala, Sweden) with a 12-
lead ECG (CASE/Carestream, GE Healthcare, Freiburg,
Germany) was used. A starting load between 30–100
Watts (W) and an incremental mechanical load between
10–20 W/min was set individually for each participant
depending on the predicted work capacity according to
the standard reference values and the participant’s esti-
mated fitness level [19]. A pedal frequency of 60 revolu-
tions per minute was kept during the entire test. When
the participant reached a HR exceeding 110 beats per mi-
nute and a rating of perceived exertion of 13 out of 20 ac-
cording to the Borg’s RPE scale the ramp was ceased and
work load was maintained for six minutes. HR was mea-
sured at the end of the fifth and sixth minutes of this
stage, from which the mean HR was computed. The
VO2max was estimated using the Åstrand-Rhyming
nomogram [8] based on mean HR at steady state and the
mechanical load. With increasing age maximal HR de-
creases. The estimated VO2max was therefore corrected for
age. Alternatively, the estimated VO2max was adjusted for
maximal HR assessed at the maximal cycle test (measured
VO2max test).
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dicted maximal HR to estimate VO2max by the Åstrand
test, the following formulas were used:
a) the Fox-Haskell formula (220 - age) [9]
b) the Tanaka formula (208–0.7 · age) [10]
c) the Nes formula (211–0.64 · age) [11]
It should be noted that there is a similarity between
names of the Fox-walk test and the Fox-Haskell formula
(220-age) and these should not be mixed up.
Test for maximal oxygen uptake (measured VO2max test)
Oxygen uptake and carbon dioxide elimination were
measured during a ramp cycle ergometer test until vol-
itional exhaustion. The same cycle ergometer cycle was
used for the measured VO2max test for the Åstrand test
and the starting work load and ramp protocol was reset
according to the previous Åstrand test. The participant
was instructed to keep a cadence of 60 revolutions per
minute until volitional exhaustion. Oxygen uptake and
carbon dioxide elimination was measured by a breath-
by-breath method, while the participant wore a Hans
Rudolph mask (Vmax ENCORE 229, VIASYS™ Healthcare,
Palm springs, CA/USA). Peak workload and HR were
recorded as well as the peak oxygen uptake and carbon
dioxide elimination averaged over a 20 second interval.
True maximal workload and oxygen uptake require a
high degree of engagement by both participant and
staff, and are seldom reached in a laboratory setting.
However, in line with most literature these variables
are in the present study referred as maximal HR and
VO2max. The test was accepted to be limited by the car-
dio respiratory system when the participants no longer
could maintain the targeted 60 RPM along with at least
two of the following criteria: a respiratory exchange ra-
tio (RER) >1.10, rating of perceived exertion exceeded
16 out of 20 according to the Borg’s RPE scale and a
maximal HR exceeding 90% of the estimated age-predicted
maximal HR (220 - age) [9]. The measured VO2max was
determined from the highest 20-s period during the exer-
cise before the test was interrupted. Before each test ses-
sion the system were calibrated for respiratory gases and
air flow using standardized gases and a 3 L calibration
syringe, respectively.
Data treatment and statistics
Descriptive data are presented as percentages, means
(SD) and medians (IQR) when appropriate. To test the
validity, Pearson’s correlation coefficients statistic were
calculated to determine the direction and strength of the
association between VO2max estimated by the Fox-walk
test and measured VO2max test, as well as between
VO2max estimated by the Åstrand test and measuredVO2max test. The correlation coefficient was interpreted
according to Cohen (1988), whereby 0.10-0.29 was con-
sidered small, 0.30-0.49 was considered moderate and
0.50-1.0 was considered strong association [20]. Paired
t-tests were used to test potential differences between
these measures. This test was also used to calculate the
potential differences in lower limb pain before and
after the Fox-walk test. Bland and Altman methods
were used to assess whether there was any systematic
disagreement between the submaximal tests and the
maximal test [21]. Calculations included the mean
difference between the measures, the standard devi-
ation of the differences (SDdifference) and the 95% limits
of agreement: mean ± 2 · SDdifference. For all tests, the level
of significance was set at ≤ 0.05. All analyses were
performed using StatSoft™, STATISTICA, version10.0.
Ethics approval
This study was approved, as part of the PARA 2010
study, by the Stockholm Regional Ethical Review Board
(2011/1241-32).
Results
All participants (n = 27) completed the Fox-walk test,
the Åstrand test and the measured VO2max test.
Measured VO2max test
The participants’ performance characteristics for the
VO2 max test are presented in Table 2. Twenty four of
the 27 participants achieved a respiratory exchange ratio
greater than 1.10. All participants reached a maximal
HR close to or exceeding the estimated age-predicted
maximal HR according to Fox-Haskell (220-age) and all
except one participant rated their perceived exertion as
17 or more. The self-reported lower limb pain, median
(IQR), was 9 (2–22) before and 10 (3–23) after the cycle
test with no statistically significant difference between
the ratings. Data of comparison between the measured
VO2max test, and the Fox-walk test and Åstrand tests,
respectively, are shown in Table 3.
Fox-walk test vs. measured VO2max test
Pearson’s correlation coefficients showed a strong, posi-
tive relationship between the estimated and measured
VO2max and ranged between r = 0.52 and r = 0.81
(Figure 1A-F and Table 3). The paired t-test revealed
a significant difference between the tests, and the Fox-walk
test overestimated VO2max by almost 30% (Table 3). The
Bland and Altman analyses showed that the distribution
of differences of VO2max was independent of VO2max
levels, regardless if it was expressed in l/min or adjusted
for weight expressed in ml · kg−1 · min−1 (Figure 2A-F).
The 95% limits of agreement for the estimated VO2max
were wide, ranging from −0.3 to 1.8 l/min and −3.4 to
Table 2 Data characteristics of measured VO2max test
(n = 27)
Characteristics Mean (SD)
RER at measured VO2 max 1.16 (0.08)
HR at rest (BPM) 72 (10)
HR at measured VO2 max (BPM) 171 (10)
Percent of age-predicted max HR Fox-Haskell* 108 (6)
Percent of age-predicted max HR Tanaka** 104 (5)
Percent of age-predicted max HR Nes*** 99 (5)
BP Systolic at rest (mmHg) 137 (18)
BP Diastolic at rest (mmHg) 85 (9)
BP Systolic at measured VO2 max(mmHg) 188 (20)
Maximal workload (Watt) 181 (61)
Measured VO2 max (l/min)
total group 2.38 (0.88)
female 2.81 (0.43)
male 4.54 (0.79)
Measured VO2 max (ml · kg
−1 · min−1)
total group 33.2 (7.8)
female 31.6 (7.0)
male 40.0 (8,2)
Perceived exertion (Borg’s RPE scale 6–20) 18 (17–19)
Measured VO2max = maximal oxygen uptake, RER = respiratory exchange ratio,
HR = heart rate, BPM = beats per minute, *percent of age predicted maximal
HR according to Fox-Haskell formula (220 – age), **according to Tanakas formula
(208–0.7 · age), ***according to Nes’ formula (211–0.64 · age), BP = blood pressure,
RPE = ratings of perceived exertion.
Table 3 VO2max values from the measured VO2max test
and the submaximal tests
l/min Mean (SD) p-value r-value1 p-value
Measured VO2max 2.4 (0.8) - - -
Fox-walk test 3.2 (0.9) 0.004 0.81 <0.001
Åstrand test corrected for age 2.2 (0.6) 0.039 0.82 <0.001
Åstrand test corrected for
maximal HR
2.4 (0.6) 0.956 0.82 <0.001
Fox-Haskell (220-age) 2.2 (0.6) 0.037 0.82 <0.001
Tanaka (208–0.7 · age) 2.3 (0.6) 0.289 0.81 <0.001
Nes (211–0.64 · age) 2.4 (0.7) 0.752 0.81 <0.001
ml · kg1 · min-1 Mean (SD) p-value r-value p-value
Measured VO2max 33 (8) - - -
Fox-walk test 44 (2) <0.001 0.52 0.006
Åstrand test corrected for age 31 (8) 0.064 0.68 <0.001
Åstrand test corrected for
maximal HR
34 (8) 0.593 0.65 <0.001
Fox-Haskell (220-age) 31 (8) 0.059 0.68 <0.001
Tanaka (208–0.7 · age) 32 (8) 0.546 0.66 <0.001
Nes (211–0.64 · age) 34 (8) 0.345 0.66 <0.001
Paired t-test comparisons between the measured VO2max values and the six
estimated VO2 max values and Pearson’s correlation coefficient’s between the
tests (n = 27).
1Pearson’s correlation coefficient, VO2max = maximum oxygen uptake,
HR = heart rate.
P≤0.05 in bold.
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limb pain was, median (IQR), 19 (7–28) before and
21 (8–39) after the Fox-walk test with no statistically
significant differences between the ratings. Perceived
exertion was, median (IQR), 15 (9–17) after the Fox-
walk test.
Åstrand test corrected for age vs. measured VO2max test
Pearson’s correlation coefficients showed a strong and
positive relationship between the estimated and mea-
sured VO2max and ranged between r = 0.68 and r = 0.82
(Figure 1A-F and Table 3). The paired t-test revealed a
significant difference between the tests, and the Åstrand
test underestimated VO2max by almost 10% (Table 3).
The Bland and Altman analyses showed that the distri-
bution of differences of VO2max was independent of
VO2max levels, regardless if it was expressed in l/min
or adjusted for weight expressed in ml · kg−1 · min−1,
respectively (Figure 2A-F). The 95% limits of agree-
ment ranged from −1.2 to 0.8 l/min and −14.4 to
9.8 ml · kg−1 · min−1, respectively and in most cases differ-
ences between measures were less than 0.6 l/min and
8 ml · kg−1 · min−1, respectively.Åstrand test corrected for assessed maximal HR vs.
measured VO2max test
Pearson’s correlation coefficients showed a strong, posi-
tive relationship between the estimated and measured
VO2max and ranged between r = 0.65 and r = 0.82
(Figure 1A-F and Table 3). The paired t-test did not
reveal a significant difference between the tests (Table 3).
The Bland and Altman analysis demonstrated good agree-
ment between the two tests, and no systematic over- or
underestimation were present (Figure 2A-F). The 95%
limits of agreement ranged from −1 to 1 l/min and −12.1
to 13.4 ml · kg−1 · min−1. Several cases were distributed
around zero and in most cases the differences between the
measures were less than 0.3 l/min and 8 ml · kg−1 · min−1.
Åstrand test corrected for age predicted maximal HR with
different formulas vs. measured VO2max test
Pearson’s correlation coefficients showed a strong, positive
relationship between estimated and measured VO2max and
ranged between r = 0.66 and r = 0.82 (Figure 3A-F and
Table 3). The paired t-test combined with the Bland and
Altman analysis showed that maximal HR correction
according to the Fox-Haskell formula (220-age) underesti-
mated VO2max expressed in l/min (Figure 4A-F and
Table 3). No statistically significant underestimation was
found when maximal HR was corrected according to the
l/min ml·kg-1·min-1
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Figure 1 Measured vs estimated maximal oxygen uptake (VO2max). Correlations between measured VO2max and VO2max estimated with the
Fox-walk test (A-B), expressed in l/min (left) and ml · kg−1 · min−1 (right). Correlations between measured VO2max and VO2max estimated with the Åstrand test
corrected for age (C-D) and corrected for maximal HR (E-F), expressed in l/min (left) and ml (right). The line of identity is plotted in the figures (n = 27).
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for values expressed in l/min or for values expressed in
ml · kg−1 · min−1 (Figure 4A-F and Table 3).Discussion
This is the first study to examine the criterion validity of
the submaximal Fox-walk test, a self-monitoring test
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Figure 2 Bland and Altman plots of measured and estimated maximal oxygen uptake (VO2max). Differences of VO2max in l/min (left) and
ml · kg−1 · min−1 (right) between the Fox-walk test and the measured VO2max test, plotted against the mean of VO2max of these two tests (A-B).
Differences of VO2max in l/min (left) and ml · kg
−1 · min−1 (right) between the Åstrand test and the measured VO2max test, plotted against the mean
of the VO2max of these two tests. The estimated VO2max with the Åstrand test is corrected for age (C-D) and assessed maximal heart rate (E-F),
respectively. The plotted lines in the figures show the 95% limits of agreement (n = 27).
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Figure 3 Measured vs estimated maximal oxygen uptake (VO2max). Correlations between measured VO2max and VO2max estimated with the
Åstrand test using age predicted maximal HR corrections with the Fox-Haskell (A-B), the Tanaka (C-D) and the Nes (E-F) formulas, respectively,
expressed in l/min (left) and ml · kg−1 · min−1 (right). The line of identity is plotted in the figures (n = 27).
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test overestimated VO2 max substantially, which should
be taken into account when interpreting the results.However, despite this limitation the test could be useful
for self-monitoring of aerobic fitness. To the best of our
knowledge, this is also the only study to date which has
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Figure 4 Bland and Altman plots of estimated and measured maximal oxygen uptake (VO2max). Differences of VO2max in l/min (left)
and ml · kg1 · min−1 (right) between Åstrand test and the measured VO2max test plotted against the mean of these two tests. The estimated
VO2max with the Åstrand test is corrected for age predicted maximal heart rate with the Fox-Haskell (A-B), the Tanaka (C-D) and the Nes (E-F) formulas,
respectively. The plotted lines in the figures show the 95% limits of agreement (n = 27).
Nordgren et al. BMC Musculoskeletal Disorders 2014, 15:305 Page 9 of 11
http://www.biomedcentral.com/1471-2474/15/305
Nordgren et al. BMC Musculoskeletal Disorders 2014, 15:305 Page 10 of 11
http://www.biomedcentral.com/1471-2474/15/305examined the criterion validity of the submaximal
Åstrand test in a population with RA and the test is con-
sidered to be a valid instrument to estimate VO2max in
physically active people with RA.
The Fox-walk test overestimated VO2max by almost
30%, independent of participants’ levels of fitness. The
overestimation could be explained by several factors.
Some participants rated a low perceived exertion (five
rated lower than 13) indicating that they should have
performed the test running, as recommended for indi-
viduals with a high VO2max. However, this could conse-
quently have lead to an underestimation of VO2max and
not an overestimation, as was the case with the Fox-
walk test. Pain in lower limbs is likely to affect perform-
ance in a population with RA and could have had an
impact on the test results. This was probably not a limit-
ing factor for the participants in the present study, indi-
cated by the low rating of lower limb pain after walking
the track and it is therefore unlikely that this could have
influenced the associations between the two methods.
Another factor explaining the discrepancy between the
two methods could have been that the measured VO2max
test was not performed with maximal exhaustion. How-
ever, a majority of the participants met the criteria for a
maximal test and therefore a systematic interruption of
the test at a submaximal level of exhaustion is unlikely
and could not explain the large difference between the
Fox walk test and the measured VO2 max test.
The submaximal Åstrand test showed a strong correl-
ation with the VO2max test when corrected for age
expressed in l/min (r = 0.82) but weaker correlation
when expressed in ml · kg-1·min−1 (r = 0.68). The slightly
lower relative (ml · kg−1 · min−1 ) compared to the abso-
lute (l/min) value should be regarded as a mathematic
consequence of weight index giving a lower range in re-
lation to the mean and thereby less good prerequisites
for getting high r-values. In the present study, the
Åstrand test underestimated VO2max by 10%, which is in
accordance with previous studies on healthy individuals
[22,23], although an overestimation also has been shown
[24]. The assumption of a linear relationship between
heart rate and VO2max, makes the estimation of VO2max
from a submaximal test strongly dependent on the
accuracy of the age-predicted maximal HR. Tanaka’s
(208–0.7 · age) [10] and Nes (211–0.64 · age) [11] formu-
las turned out to better predict maximal HR compared
to the Fox-Haskell formula (220-age) [9], (99%, 104%
and 108%, respectively, of assessed maximal HR). When
age-correction was made with the use of these three
alternative age-predicted HR max formulas, the wide-
spread Fox-Haskell formula underestimated VO2max by
the same degree as Åstrand corrected for age [8,25],
whereas the two formulas by Tanaka and Nes seem to
come closer to the measured VO2max .Some limitations associated with this study need to
be considered. The population in the present study
participated in an intervention promoting physical ac-
tivity and they had exercised regularly during the past
year, and were well-trained. Additionally the partici-
pants in this study had low disease-activity compared
to people with RA in general. In addition, a majority
of the individuals included in the present study were fe-
males which also could have hampered the generalizability
of the results. Three subjects used low-dose beta-
adrenergic antagonists for treatment of hypertension.
This could have influenced the study results according
to beta blockers side-effects on HR response. However,
all subjects in this study reached a maximal HR be-
tween 98% and 120% (median 107%) of the estimated
age-predicted maximal HR. According to the normal
HR response in these subjects, use of β-blocker antihy-
pertensive treatment had no or limited effects on HR
response in relation to work load. When performing a
cycle test for the first time, anxiety and inexperience
with the test situation could have an impact on the
test result. The work efficiency could be lower and the
ratio between the HR and the work load could be
higher, consequently leading to an underestimation of
VO2max. However, this was probably not the case in
this study as all participants had performed the test at
least twice and were familiar with exercise testing. A
strength in our study was that the same biomedical
scientist (T Ö) conducted all cycle ergometry tests.
With regards to the Fox-walk test, the test was per-
formed on a single track and no other tracks were
tested, thus future studies should consider that differ-
ent results may be obtained on other tracks.
Conclusions
The Fox-walk test cannot be used confidently for esti-
mating VO2max on the bases of the correlation and
agreement analyses. However, the test may still be used
but with consideration of its limitations when interpret-
ing the results. We strongly recommend and encourage
further development of the test, since it is a promising
test for self-monitoring VO2max by individuals outside
of a clinical setting, and could also be used by profes-
sionals in the clinic. Provided that the Åstrand test is
standardized according to the test manual, it should be
considered as highly valid and feasible [26] in physically
active people with RA and is recommended for use by
health professionals in both clinical and research set-
tings. The newly developed formulas by Tanaka and
Nes for predicting maximal heart rate according to age
are preferable [10,11], but the Åstrand test is still valid
with the use of its own age prediction VO2max or with
the Fox-Haskell formula for predicting maximal heart
rate.
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